CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MK0653, ezetimibe / Duration of Treatment: 30 Weeks - Phase 3 | OGN Pipeline | CatalystAlert